IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
about
Regulation of Cellular Identity in CancerFunctional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic CancerPivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation.The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation.NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.Targeting reactive oxygen species in development and progression of pancreatic cancer.IER3 in pancreatic carcinogenesis.Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K.Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?IER3 Promotes Expansion of Adipose Progenitor Cells in Response to Changes in Distinct Microenvironmental Effectors.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
P2860
Q28086849-E99DE9A9-1522-4DCC-8A19-D34332D3AEA6Q28115653-215FC5E2-54C3-4C21-B340-ED0281636A5DQ36296837-47110EFD-B101-4928-B3CA-3F0710DFAEA7Q36329451-389C5CF5-53A3-45A6-ADDA-31E7BA3E2054Q37151496-3643090F-05A6-4DC5-A208-E0DD196263C9Q37482829-B80A9FCE-22EB-4004-9157-80E077DBBCD5Q37616743-E251EE7F-DAB8-4B4F-BC18-863EC5CDE8DDQ39007517-7CBA1101-1FB3-4AC7-A713-3BCD600368D2Q43228335-26C1DAB7-238A-4A55-9FCD-97ACF3984D8FQ50080994-9DCA6D0F-76ED-4F7D-8740-1622C41B8FAAQ52715499-FA6E2575-7568-4574-9DDA-51B4FF8DBEF8Q53562830-8DAEC8FF-7D3F-47F7-97AD-78C2D23323C9Q55104265-53A4FB4F-78F4-4DFB-BB8C-3153A0B1B5A4Q58701024-64E5B365-2C02-4B18-AECD-4E1D04EF7070
P2860
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@ast
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@en
type
label
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@ast
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@en
prefLabel
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@ast
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@en
P2093
P2860
P356
P1476
IER3 supports KRASG12D-depende ...... aining ERK1/2 phosphorylation.
@en
P2093
Celine Loncle
Françoise Porteu
Gwen Lomberk
Juan L Iovanna
Maria Belen Lopez-Millan
Maria Noé Garcia
Raul Urrutia
Tewfik Hamidi
P2860
P304
P356
10.1172/JCI76037
P407
P577
2014-09-24T00:00:00Z